{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:55Z","timestamp":1784557075699,"version":"3.55.0"},"reference-count":10,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"\n Summary<\/jats:title>\n \n This is a report on antithyroid arthritis syndrome (AAS) which is a rare adverse effect of antithyroid agents. AAS presents with severe symptoms including myalgia, arthralgia, arthritis, fever, and skin eruption due to the use of antithyroid agents. We encountered a 55-year-old woman with severe pain in the hand and forearm and arthralgia in multiple joints, including the knee, ankle, hand, and wrist on day 23 after initiation of methimazole (MMI) for Graves\u2019 disease. Blood tests revealed elevated inflammation markers such as C-reactive protein and interleukin-6, and magnetic resonance imaging of the hands confirmed inflammation findings. After withdrawing MMI on day 25, symptoms showed a tendency toward improvement. Afterwards, inflammation markers also dropped to an almost normal range. In addition to the above findings, the absence of anti-neutrophil cytoplasmic antibodies and most vasculitis symptoms such as nephritis, skin, or pulmonary lesions led to the diagnosis of AAS. A resolution of symptoms, except for mild arthralgia in the second to fourth fingers of the right hand, was observed 61 days after discontinuation of MMI. Although the pathogenesis is unclear, the positive drug lymphocyte stimulation test for MMI and the several weeks before the onset of AAS suggested involvement of a type IV allergic reaction. Based on a discussion of definitive treatment for Graves\u2019 disease, radioactive iodine ablation with\n 131<\/jats:sup>\n I, which was selected by the patient, was performed and improved her thyroid function. Our case demonstrates the importance of awareness regarding AAS, which is a rare and under-recognized, but life-threatening adverse effect of antithyroid agents.\n <\/jats:p>\n <\/jats:sec>\n \n Learning points<\/jats:title>\n \n \n Clinicians should be aware of the possibility of developing antithyroid arthritis syndrome (AAS) in patients treated with antithyroid medications, which can lead to severe migratory polyarthritis.<\/jats:p>\n <\/jats:list-item>\n \n Prompt cessation of the antithyroid agent is essential for the resolution of AAS.<\/jats:p>\n <\/jats:list-item>\n \n Anti-neutrophil cytoplasmic antibody (ANCA) negativity is needed to differentiate from antithyroid agent-induced ANCA-associated vasculitis, which shows arthritis similar to AAS.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:sec>","DOI":"10.1530\/edm-23-0031","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:54:17Z","timestamp":1688446457000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":3,"title":["Antithyroid arthritis syndrome caused by methimazole in a patient with Graves\u2019 disease"],"prefix":"10.1530","volume":"2023","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7864-7785","authenticated-orcid":true,"given":"Muneo","family":"Kawasumi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8562-5939","authenticated-orcid":true,"given":"Mitsunobu","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yoshii","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiro","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"The Endocrinologist","first-page":"457","article-title":"The side effects of anti-thyroid drugs","volume":"1999","author":"Cooper","unstructured":"Cooper DS. The side effects of anti-thyroid drugs. The Endocrinologist1999457\u2013476."},{"key":"bib2","series-title":"Thyroid","first-page":"1343","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","unstructured":"Ross DSBurch HBCooper DSGreenlee MCLaurberg PMaia ALRivkees SASamuels MSosa JAStan MN2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid2016261343\u20131421. (https:\/\/doi.org\/10.1089\/thy.2016.0229)"},{"key":"bib3","series-title":"Arthritis and Rheumatism","first-page":"227","article-title":"The antithyroid arthritis syndrome reviewed","volume":"27","author":"Shabtai","year":"1984","unstructured":"Shabtai RShapiro MSOrenstein DTaragan R & Shenkman L. The antithyroid arthritis syndrome reviewed. Arthritis and Rheumatism198427227\u2013229. (https:\/\/doi.org\/10.1002\/art.1780270216)"},{"key":"bib4","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"868","article-title":"In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis","volume":"58","author":"Wall","year":"1984","unstructured":"Wall JRFang SLKuroki TIngbar SH & Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. Journal of Clinical Endocrinology and Metabolism198458868\u2013872. (https:\/\/doi.org\/10.1210\/jcem-58-5-868)"},{"key":"bib5","series-title":"Internal Medicine (Tokyo, Japan)","first-page":"3627","article-title":"Antithyroid arthritis syndrome: a case report and review of the literature","volume":"55","author":"Takaya","year":"2016","unstructured":"Takaya KKimura N & Hiyoshi T. Antithyroid arthritis syndrome: a case report and review of the literature. Internal Medicine (Tokyo, Japan)2016553627\u20133633. (https:\/\/doi.org\/10.2169\/internalmedicine.55.7379)"},{"key":"bib6","series-title":"JAMA","article-title":"Antinuclear antibodies and propylthiouracil therapy","volume":"220","author":"Cetina","year":"1972","unstructured":"Cetina JAFishbein E & Alarc\u00f3n-Segovia D. Antinuclear antibodies and propylthiouracil therapy. JAMA1972220 1012. (https:\/\/doi.org\/10.1001\/jama.1972.03200070100019)"},{"key":"bib7","series-title":"Radiology Case Reports","first-page":"917","article-title":"Thyroid acropachy: a rare skeletal manifestation of autoimmune thyroid disease","volume":"14","author":"Jadidi","year":"2019","unstructured":"Jadidi JSighary MEfendizade AGrigorian ALehto SA & Kolla S. Thyroid acropachy: a rare skeletal manifestation of autoimmune thyroid disease. Radiology Case Reports201914917\u2013919. (https:\/\/doi.org\/10.1016\/j.radcr.2019.04.021)"},{"key":"bib8","series-title":"Science","first-page":"810","article-title":"Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","unstructured":"Jiang XKhursigara G & Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science1994266810\u2013813. (https:\/\/doi.org\/10.1126\/science.7973636)"},{"key":"bib9","series-title":"Scandinavian Journal of Rheumatology","article-title":"Methimazole and arthritis","volume":"19","author":"Rafter","year":"1990","unstructured":"Rafter GW. Methimazole and arthritis. Scandinavian Journal of Rheumatology199019 385. (https:\/\/doi.org\/10.3109\/03009749009096795)"},{"key":"bib10","series-title":"Rheumatology","first-page":"1452","article-title":"Colchicine as a new therapeutic option for antithyroid arthritis syndrome","volume":"59","author":"Mancuso","year":"2020","unstructured":"Mancuso GBoffini NDagna L & Della-Torre E. Colchicine as a new therapeutic option for antithyroid arthritis syndrome. Rheumatology2020591452\u20131453. (https:\/\/doi.org\/10.1093\/rheumatology\/kez547)"}],"container-title":["Endocrinology, Diabetes & Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2023\/3\/EDM23-0031.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2023\/3\/EDM23-0031.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2023\/3\/EDM23-0031.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:12Z","timestamp":1784555292000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":10,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/edm-23-0031","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}